COX-2 expression in adenoma: an imperfect marker for chemoprevention

Gut. 2010 May;59(5):568-9. doi: 10.1136/gut.2009.200014.
No abstract available

Publication types

  • Kommentar

MeSH terms

  • Adenoma / enzymology*
  • Adenoma / prevention & control
  • Anticarcinogenic Agents / therapeutic use*
  • Aspirin / analogs & derivatives
  • Aspirin / therapeutic use
  • Biomarkers, Tumor / metabolism
  • Colorectal Neoplasms / enzymology*
  • Colorectal Neoplasms / prevention & control
  • Cyclooxygenase 2 / metabolism*
  • Cyclooxygenase Inhibitors / therapeutic use
  • Humans
  • Lysine / analogs & derivatives
  • Lysine / therapeutic use
  • Neoplasm Recurrence, Local / enzymology
  • Neoplasm Recurrence, Local / prevention & control

Substances

  • Anticarcinogenic Agents
  • Biomarkers, Tumor
  • Cyclooxygenase Inhibitors
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Lysine
  • Aspirin
  • acetylsalicylic acid lysinate